An improved HPLC assay with fluorescence detection for the determination of domperidone and three major metabolites for application to in vitro drug metabolism studies
Authors:
- Chantal SimardCSChantal Simard
- Jacques TurgeonJTJacques Turgeon
- 1 June 2007
- journal article
- Published by Elsevier in Journal of Chromatography B
- Vol. 852 (1-2) , 611-616
Abstract
No abstract availableKeywords
This publication has 15 references indexed in Scilit:
- Characterization of human cytochrome P450 enzymes catalyzing domperidone N‐dealkylation and hydroxylation in vitroBritish Journal of Clinical Pharmacology, 2004
- Identification of the cytochrome P450 enzymes involved in the metabolism of domperidoneXenobiotica, 2004
- Sequence diversity in CYP3A promoters and characterization of the genetic basis of polymorphic CYP3A5 expressionNature Genetics, 2001
- Domperidone Should Not Be Considered a No-Risk Alternative to Cisapride in the Treatment of Gastrointestinal Motility DisordersCirculation, 2000
- High-performance liquid chromatographic analysis for the determination of domperidone in human plasmaJournal of Chromatography B: Biomedical Sciences and Applications, 2000
- Determination of domperidone in human serum and human breast milk by high-performance liquid chromatography–electrospray mass spectrometryJournal of Chromatography B: Biomedical Sciences and Applications, 1999
- Domperidone: A Peripherally Acting Dopamine 2 -Receptor AntagonistAnnals of Pharmacotherapy, 1999
- DomperidoneDrugs, 1982
- On the pharmacokinetics of domperidone in animals and man III. Comparative study on the excretion and metabolism of domperidone in rats, dogs and manEuropean Journal of Drug Metabolism and Pharmacokinetics, 1981
- On the pharmacokinetics of domperidone in animals and man I. Plasma levels of domperidone in rats and dogs. Age related absorption and passage through the blood brain barrier in ratsEuropean Journal of Drug Metabolism and Pharmacokinetics, 1981